BHC
Bausch Health Companies Inc.
Key Financials
Net Income
$157.0M
↑ 441.3%
Operating Income
$1.8B
↑ 17.3%
Revenue
$10.3B
↑ 6.7%
EPS (Diluted)
$0.42
↑ 423.1%
Total Assets
$26.4B
↓ 0.6%
Cash & Equivalents
$1.3B
↑ 10.8%
Total Liabilities
$26.0B
↓ 3.2%
Shareholders' Equity
$-554000000.00
↑ 56.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 7/30/2026 | View on SEC |
| 8-K | 7/29/2026 | View on SEC |
| 4 | 7/20/2026 | View on SEC |
| 4 | 7/17/2026 | View on SEC |
| 4 | 7/15/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 4 | 7/2/2026 | View on SEC |
| 8-K | 7/1/2026 | View on SEC |
| SD | 6/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BHC |
| Company Name | Bausch Health Companies Inc. |
| CIK | 885590 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NJ |
| Phone | 514-744-6792 |